Revolution Medicines, Inc.
RVMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$600 | -$436 | -$249 | -$187 |
| Dep. & Amort. | $12 | $9 | $10 | $7 |
| Deferred Tax | -$1 | -$4 | -$0 | $0 |
| Stock-Based Comp. | $0 | $0 | $31 | $21 |
| Change in WC | $1 | $41 | -$13 | $9 |
| Other Non-Cash | $30 | $40 | -$3 | $3 |
| Operating Cash Flow | -$557 | -$351 | -$224 | -$147 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$10 | -$8 | -$11 | -$7 |
| Net Acquisitions | $0 | $0 | $13 | $136 |
| Inv. Purchases | -$2,137 | -$1,059 | -$613 | -$671 |
| Inv. Sales/Matur. | $1,593 | $724 | $599 | $536 |
| Other Inv. Act. | $0 | $0 | -$13 | -$136 |
| Investing Cash Flow | -$554 | -$343 | -$24 | -$142 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $959 | $392 | $298 | $291 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $837 | $3 | $3 |
| Financing Cash Flow | $959 | $1,229 | $301 | $294 |
| Forex Effect | -$1 | -$1 | $0 | $0 |
| Net Chg. in Cash | -$153 | $535 | $53 | $5 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $696 | $161 | $110 | $105 |
| End Cash | $543 | $696 | $163 | $110 |
| Free Cash Flow | -$568 | -$358 | -$235 | -$154 |